Biblio
Chromatin remodeler CHD7 targets active enhancer region to regulate cell type-specific gene expression in human neural crest cells. Sci Rep. 2022;12(1):22648.
. Human-induced pluripotent stem cell-derived neural stem/progenitor cell ex vivo gene therapy with synaptic organizer CPTX for spinal cord injury. Stem Cell Reports. 2024.
Laying the groundwork for a first-in-human study of an iPSC-based intervention for spinal cord injury. Stem Cells. 2018.
Mesenchymal properties of iPSC-derived neural progenitors that generate undesired grafts after transplantation. Commun Biol. 2023;6(1):611.
Modulation by DREADD reveals the therapeutic effect of human iPSC-derived neuronal activity on functional recovery after spinal cord injury. Stem Cell Reports. 2022;17(1):127-142.
Non-Cell-Autonomous Neurotoxicity in Parkinson's Disease Mediated by Astroglial α-Synuclein. Stem Cell Reports. 2019;12(2):183-185.
. .